Dronabinol effective in reducing neuropathic pain in multiple sclerosis after 48-week treatment

Study Type:Therapy

OE Level Evidence:2

Journal Level of Evidence:N/A

Dronabinol is a safe long-term treatment option for neuropathic pain patients

Eur Neurol. 2017;78(5-6):320-329.

Contributing Authors: S Schimrigk M Marziniak C Neubauer EM Kugler G Werner D Abramov-Sommariva

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

No credit card required

JOIN Forgot Password?

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.